Article

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer…

eLife · 2014 · Yubao Wang, author Young-Mi Lee, author Lukas Baitsch, author Alan Huang, author Yi Xiang, author Haoxuan Tong, author Ana Lako, author Thanh Von, author Christine Choi, author Elgene Lim, author Junxia Min, author Li Li, author Frank Stegmeier, author Robert Schlegel, author Michael J Eck, author Nathanael S Gray, author Timothy J Mitchison, author Jean J Zhao, author

Key facts

Title MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
First author Yubao Wang, author Young-Mi Lee, author Lukas Baitsch, author Alan Huang, author Yi Xiang, author Haoxuan Tong, author Ana Lako, author Thanh Von, author Christine Choi, author Elgene Lim, author Junxia Min, author Li Li, author Frank Stegmeier, author Robert Schlegel, author Michael J Eck, author Nathanael S Gray, author Timothy J Mitchison, author Jean J Zhao, author
Journal eLife
Published May 20, 2014
DOI 10.7554/eLife.01763
Devices mentioned K010696, K042152, K073490, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 6 more
Product codes mentioned CDT, CEO, CFN, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DFZ and 6 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature